Breast Carcinoma Amplified Sequence 2 (BCAS2) (C-Term) Peptide
BCAS2
Reactivité: Humain
BP
Sodium azide
-
- Antigène Tous les produits BCAS2
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Protein Region
- C-Term
- Origine
- Humain
- Application
- Blocking Peptide (BP)
- Attributs du produit
-
14 amino acids near the carboxy terminus of human BCAS2.
Human
-
-
- Indications d'application
- BCAS2 pepide is used for blocking the activity of BCAS2.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Date de péremption
- 12 months
-
- Antigène
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Synonymes
- DAM1 Peptide, SPF27 Peptide, Snt309 Peptide, 6430539P16Rik Peptide, AI132645 Peptide, C76366 Peptide, C80030 Peptide, BCAS2 Peptide, cb302 Peptide, zgc:101730 Peptide, BCAS2, pre-mRNA processing factor Peptide, breast carcinoma amplified sequence 2 Peptide, breast carcinoma amplified sequence 2 L homeolog Peptide, BCAS2 Peptide, Bcas2 Peptide, bcas2 Peptide, bcas2.L Peptide, CpipJ_CPIJ003889 Peptide
-
Vous êtes ici:
